Harold Moses

1.3k total citations
19 papers, 492 citations indexed

About

Harold Moses is a scholar working on Pathology and Forensic Medicine, Oncology and Neurology. According to data from OpenAlex, Harold Moses has authored 19 papers receiving a total of 492 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pathology and Forensic Medicine, 9 papers in Oncology and 5 papers in Neurology. Recurrent topics in Harold Moses's work include Multiple Sclerosis Research Studies (9 papers), Polyomavirus and related diseases (7 papers) and Fungal Plant Pathogen Control (2 papers). Harold Moses is often cited by papers focused on Multiple Sclerosis Research Studies (9 papers), Polyomavirus and related diseases (7 papers) and Fungal Plant Pathogen Control (2 papers). Harold Moses collaborates with scholars based in United States, Spain and Switzerland. Harold Moses's co-authors include Siddharama Pawate, Subramaniam Sriram, Andre H. Lagrange, Inan Olmez, Howard S. Kirshner, Subramaniam Sriram, Annette Langer‐Gould, T. Jock Murray, David Brandes and Peter F. Wright and has published in prestigious journals such as Neurology, Journal of the Neurological Sciences and The Pediatric Infectious Disease Journal.

In The Last Decade

Harold Moses

19 papers receiving 479 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Harold Moses United States 12 176 145 109 94 85 19 492
Sorena Kiani‐Alikhan United Kingdom 10 58 0.3× 64 0.4× 55 0.5× 44 0.5× 80 0.9× 19 631
Çiçek Bayındır Türkiye 13 130 0.7× 152 1.0× 30 0.3× 54 0.6× 91 1.1× 34 585
Medha Tatke India 16 197 1.1× 42 0.3× 27 0.2× 82 0.9× 144 1.7× 59 665
Sertaç İşlekel Türkiye 13 199 1.1× 159 1.1× 26 0.2× 105 1.1× 68 0.8× 24 699
Daniela Alberti Italy 14 276 1.6× 133 0.9× 25 0.2× 24 0.3× 31 0.4× 21 431
Meng‐Ying Hsieh Taiwan 12 165 0.9× 38 0.3× 42 0.4× 39 0.4× 97 1.1× 40 468
W. A. Sheremata United States 7 130 0.7× 134 0.9× 37 0.3× 20 0.2× 54 0.6× 8 592
RK Gherardi France 7 178 1.0× 73 0.5× 43 0.4× 15 0.2× 62 0.7× 9 404
Pamela S. Chavis United States 14 120 0.7× 70 0.5× 34 0.3× 44 0.5× 76 0.9× 34 473
Nicky Dunn Sweden 12 53 0.3× 90 0.6× 27 0.2× 40 0.4× 60 0.7× 16 340

Countries citing papers authored by Harold Moses

Since Specialization
Citations

This map shows the geographic impact of Harold Moses's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harold Moses with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harold Moses more than expected).

Fields of papers citing papers by Harold Moses

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harold Moses. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harold Moses. The network helps show where Harold Moses may publish in the future.

Co-authorship network of co-authors of Harold Moses

This figure shows the co-authorship network connecting the top 25 collaborators of Harold Moses. A scholar is included among the top collaborators of Harold Moses based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harold Moses. Harold Moses is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
Cohan, Stanley, Harold Moses, Jonathan Calkwood, et al.. (2018). Clinical outcomes in patients with relapsing-remitting multiple sclerosis who switch from natalizumab to delayed-release dimethyl fumarate: A multicenter retrospective observational study (STRATEGY). Multiple Sclerosis and Related Disorders. 22. 27–34. 42 indexed citations
3.
Gelfand, Jeffrey M., Michael Bradshaw, Barney J. Stern, et al.. (2017). Infliximab for the treatment of CNS sarcoidosis. Neurology. 89(20). 2092–2100. 124 indexed citations
4.
5.
Montalbán, Xavier, Bruce A. Cohen, Thomas Leist, et al.. (2016). Efficacy of Cladribine Tablets as Add-On to IFN-beta Therapy in Patients with Active Relapsing MS: Final Results from the Phase II ONWARD Study (P3.029). Neurology. 86(16_supplement). 11 indexed citations
6.
7.
Moses, Harold, et al.. (2015). Efficacy of oral Multiple Sclerosis therapies in patients switching from natalizumab (P3.290). Neurology. 84(14_supplement). 1 indexed citations
8.
Taylor, Bruce, Harold Moses, Friedemann Paul, Gustavo Cruz, & Mark Rametta. (2015). Treatment of Multiple Sclerosis – Relationship between Vitamin D and Interferon β-1b. European Neurological Review. 10(2). 124–124. 1 indexed citations
9.
Montalbán, Xavier, Bruce A. Cohen, Thomas Leist, et al.. (2013). Oral Cladribine as Add on to IFN β Therapy in Patients with Active Multiple Sclerosis: Results from the Phase II ONWARD Study (P07.099). Neurology. 80(7_supplement). 2 indexed citations
10.
Moses, Harold, Mark Freedman, Ludwig Kappos, et al.. (2013). Pre-Defined Subgroups Analyses of TOWER, a Placebo-Controlled Phase 3 Trial of Teriflunomide in Patients with Relapsing Multiple Sclerosis (S41.006). Neurology. 80(7_supplement). 4 indexed citations
11.
Olmez, Inan, Harold Moses, Subramaniam Sriram, et al.. (2013). Diagnostic and therapeutic aspects of Hashimoto's encephalopathy. Journal of the Neurological Sciences. 331(1-2). 67–71. 97 indexed citations
12.
Pawate, Siddharama, Anita Agarwal, Harold Moses, & Subramaniam Sriram. (2009). The spectrum of Susac’s syndrome. Neurological Sciences. 30(1). 59–64. 25 indexed citations
13.
Moses, Harold & David Brandes. (2008). Managing adverse effects of disease-modifying agents used for treatment of multiple sclerosis. Current Medical Research and Opinion. 24(9). 2679–2690. 18 indexed citations
14.
Harper, Elizabeth I., Harold Moses, & Andre H. Lagrange. (2007). Occult celiac disease presenting as epilepsy and MRI changes that responded to gluten-free diet. Neurology. 68(7). 533–534. 12 indexed citations
15.
Weitkamp, Jörn-Hendrik, et al.. (2004). Influenza A virus-associated acute necrotizing encephalopathy in the United States. The Pediatric Infectious Disease Journal. 23(3). 259–263. 46 indexed citations
16.
Langer‐Gould, Annette, Harold Moses, & T. Jock Murray. (2004). Strategies for managing the side effects of treatments for multiple sclerosis. Neurology. 63(11_suppl_5). S35–41. 37 indexed citations
17.
O’Brien, Terence J., Harold Moses, D Cambier, & Gregory D. Cascino. (2002). Age of meningitis or encephalitis is independently predictive of outcome from anterior temporal lobectomy. Neurology. 58(1). 104–109. 17 indexed citations
18.
Moses, Harold & Subramaniam Sriram. (2001). An Infectious Basis for Multiple Sclerosis. BioDrugs. 15(3). 199–206. 21 indexed citations
19.
Arain, Amir, Bassel Abou‐Khalil, & Harold Moses. (2001). Hashimoto’s encephalopathy: documentation of mesial temporal seizure origin by ictal EEG. Seizure. 10(6). 438–441. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sorena Kiani‐Alikhan Breakdown of academic impact, for papers by Çiçek Bayındır Breakdown of academic impact, for papers by Medha Tatke Breakdown of academic impact, for papers by Sertaç İşlekel Breakdown of academic impact, for papers by Daniela Alberti Breakdown of academic impact, for papers by Meng‐Ying Hsieh Breakdown of academic impact, for papers by W. A. Sheremata Breakdown of academic impact, for papers by RK Gherardi Breakdown of academic impact, for papers by Pamela S. Chavis Breakdown of academic impact, for papers by Nicky Dunn
Rankless by CCL
2026